Undetectable levels of ctDNA following initial treatment are associated with improved survival.

<p>Kaplan–Meier analysis of progression-free (left panel) and overall survival (right panel) between individuals with undetectable (ctDNA = 0; blue lines) and detectable ctDNA (≥ 1; red lines). Significant differences in progression-free survival (p = 0.001) and overall survival (p = 0.0194) between undetectable and detectable groups.</p

Overview of patient enrollment, clinical follow-up and personalized ctDNA analysis.

<p>Overview of patient enrollment, clinical follow-up and personalized ctDNA analysis.</p